/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n\n \n \n \n\n \n \n \n
\n\n \n
\n  Recent News: Teva Pharmaceutical Industries Ltd.
\n \n \n\n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n
02/08/10 
8:32 AM EST 		\n \n \n TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGIONS - Hugin\n \n
02/08/10 
8:30 AM EST 		\n \n \n Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions - Business Wire\n \n
02/05/10 
8:30 AM EST 		\n \n \n Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits - Business Wire\n \n
02/02/10 
10:45 AM EST 		\n \n \n Teva Announces FDA Accepts BLA for XM02 - Business Wire\n \n
\n
\n \n\n\n\n\n\n
Feb 09 8:24 PM EST
\n\n\n\n \n
\n\n");